Zephyr AI

Zephyr AI is a precision medicine company that applies multi modal machine learning to large real world healthcare datasets. It works with biopharma and diagnostics companies, not individual patients, and says its tools fit into existing research and clinical workflows without requiring new assays. The platform has two parts. The AIM Suite is a set of modular, interpretable models for precision oncology: AIM Bx and AIM io predict response to small molecules or immune checkpoint inhibitors from clinically available data, AIM CDx adapts those models into companion diagnostics co developed with partners, and AIM Ex reconstructs mRNA expression from DNA based laboratory developed tests. Nexus links EHR, claims, genomics and pathology data, and supports analytics, cohort construction, synthetic control arms and model development. The vendor cites data on more than 90 million patients, including over one million with next generation sequencing in oncology. Typical uses include drug discovery, patient selection, clinical trial design and companion diagnostic development. Engagement is by partnership, started through the contact form. The vendor does not publish prices.